July 7, 2018Open Access

Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction

Structured PICO

Do non-cardiac comorbidities impact quality of life and mortality in patients with HFrEF, HFmrEF, and HFpEF?

Population

Patients with heart failure with reduced, mid-range, and preserved ejection fraction

Outcome

Quality of life (QoL) and mortality risks

Non-cardiac comorbidities are highly prevalent in HFpEF and significantly worsen quality of life and mortality, with specific impacts varying by heart failure subtype.

Abstract

The highest prevalence of comorbidities was seen in patients with HFpEF. Overall, comorbidities were associated with a lower QoL, but this was more pronounced in patients with HFrEF. Most comorbidities were associated with higher mortality risks, although the associations with diabetes were only present in patients with HFrEF.

Bookmark

View Full Paper

Cite This Study

Streng et al. (Sat,) studied this question.

synapsesocial.com/papers/69d56e0f75589c71d767d332 https://doi.org/https://doi.org/10.1016/j.ijcard.2018.04.001

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper